Polypharmacy in older adults is associated with multiple negative consequences that may
affect muscular function, independently from the presence of medical conditions. The aim of …

Background Sarcopenia and polypharmacy are both prevalent conditions in the geriatric
population, leading to poor quality of life and adverse outcomes. Objective To explore the …

Background Polypharmacy is common in older adults who are starting cancer treatment and
is associated with an increased risk of potentially inappropriate medications (PIMs) and …

Multimorbidity and, consequently, polypharmacy are highly prevalent in older adults [1, 2].
As the number of older people is continually growing [2, 3], both the concurrent use of …

Background Research on potentially inappropriate medications (PIM) and medication-
related problems (MRP) among the Chinese population with chronic diseases and …

Background Clinical evidence demonstrating a longitudinal association between prescribed
medications and sarcopenia onset is lacking. We investigated the association of …

Background The aging of our societies leads to a higher prevalence of multimorbidity and
therefore polypharmacy, which often results in inappropriate drug treatment. To address this …

Objective To evaluate the association between recently raised anticholinergic burden and
risk of acute cardiovascular events in older adults. Design Case-case-time-control study (ie …

Advancements in modern medicine have improved the quality of life across the globe and
increased the average lifespan of our population by multiple decades. Current estimates …

Polypharmacy may cause adverse health outcomes in the elderly. This study examined the
prevalence of continuous polypharmacy and hyper‐polypharmacy, factors associated with …